节点文献
基于脾-肠道菌群-原发性高血压探讨中医药调控作用
Exploration on the regulatory effect of traditional Chinese medicine based on spleen-intestinal microflora-essential hypertension
【摘要】 文章从脾-肠道菌群角度出发,通过梳理肠道菌群在原发性高血压发病过程中的相似性、关联性,结合健脾方药可调控肠道菌群紊乱而发挥降压作用,故而推测从脾论治原发性高血压的潜在效应机制与靶向调节肠道菌群有关,探讨基于肠道菌群失调论治原发性高血压的现代科学意义,亦为相关降压药物研发提供新思路。
【Abstract】 From the perspective of spleen-intestinal microflora, this paper summarizes the similarity and correlation of intestinal microflora in the pathogenesis of essential hypertension, and combines the prescription of invigorating spleen to regulate intestinal microflora disorder and play a role in lowering blood pressure. Therefore, it is speculated that the potential effect mechanism of treating essential hypertension from spleen is related to targeted regulation of intestinal microflora, and the modern scientific significance of treating essential hypertension based on intestinal microflora disorder is discussed, which also provides new ideas for the research and development of related antihypertensive drugs.
【Key words】 Essential hypertension; Intestinal microbiota; Treatment from spleen perspective; Spleen deficiency and phlegm turbidity stagnation; Microbiota;
- 【文献出处】 中华中医药杂志 ,China Journal of Traditional Chinese Medicine and Pharmacy , 编辑部邮箱 ,2024年11期
- 【分类号】R259
- 【下载频次】65